Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Share-based Compensation (2023 - 2025)

Contineum Therapeutics has reported Share-based Compensation over the past 3 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.5 million for Q4 2025, up 10.26% from a year ago — trailing twelve months through Dec 2025 was $8.9 million (up 50.93% YoY), and the annual figure for FY2025 was $10.0 million, up 47.53%.
  • Share-based Compensation for Q4 2025 was $2.5 million at Contineum Therapeutics, down from $2.6 million in the prior quarter.
  • Over the last five years, Share-based Compensation for CTNM hit a ceiling of $2.6 million in Q1 2025 and a floor of $200000.0 in Q2 2023.
  • Median Share-based Compensation over the past 3 years was $1.0 million (2024), compared with a mean of $1.4 million.
  • Biggest five-year swings in Share-based Compensation: surged 1045.5% in 2024 and later rose 10.26% in 2025.
  • Contineum Therapeutics' Share-based Compensation stood at $759000.0 in 2023, then skyrocketed by 196.57% to $2.3 million in 2024, then increased by 10.26% to $2.5 million in 2025.
  • The last three reported values for Share-based Compensation were $2.5 million (Q4 2025), $2.6 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.